
FDA Approves Second Generic of Abortion Pill, Sparking Conservative Backlash
The FDA has approved a second generic version of mifepristone, fueling backlash from anti-abortion groups and GOP leaders even as medical evidence supports its safety. The decision underscores deep divisions over reproductive access and regulatory authority.










You must be logged in to post a comment.